April 17, 2014 3:47 PM ET

Pharmaceuticals

Company Overview of Transave, Inc.

Executive Profile

Timothy G. Whitten

Former Chief Executive Officer, President and Director, Insmed Incorporated
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 4 different industries.

56$1,874,899
As of Fiscal Year 2012

Background

Mr. Timothy G. Whitten, Tim served as the Chief Executive Officer and President of Insmed Incorporated since joining in December 2010 until September 2012. Mr. Whitten served as the President and Chief Executive of Transave, Inc. since 2006. He joined Transave from Pharmacyclics where he served for approximately five years. Mr. Whitten served as Senior Vice President of Commercial Operations and Business Development of Pharmacyclics Inc., since October 2002 and served ...

Corporate Headquarters

11 Deer Park Drive
Monmouth Junction, New Jersey 08852

United States

Phone: 732-438-9434
Fax: 732-438-9435

Board Members Memberships

Former Director
2011-2012
Former Chief Executive Officer, President and Director

Education

BS
West Virginia University
MBA
Colgate W. Darden Graduate School of Business Administration

Other Affiliations

Annual Compensation

Salary$293,141
Total Annual Compensation$293,141

Stocks Options

Restricted Stock Awards$442,680
All Other Compensation$939,798
Exercisable Options$202,300
Exercisable Options Value$455,714
Total Value of Options$455,714
Total Number of Options$202,300

Total Compensation

Total Annual Cash Compensation$1,232,939
Total Short Term Compensation$293,141
Other Long Term Compensation$1,382,478
Total Calculated Compensation$1,874,899
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Brenton L. Saunders J.D.Chief Executive Officer, President, Director, Chairman of Compensation Committee and Member of Compliance Committee
Forest Laboratories Inc.
--
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
$3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Transave, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.